Amerisource Health Services LLC is recalling 4,160 vials of Azacitidine for Injection (100 mg), a prescription medication sold under the BluePoint Laboratories brand. The drug is being recalled because testing determined it was subpotent, meaning it contains less than the required amount of the active ingredient. No incidents or injuries related to this recall have been reported.
Using a subpotent medication may result in a patient receiving a lower dose than intended, which could reduce the effectiveness of the treatment.
Manufactured by Intas Pharmaceuticals Limited in India for BluePoint Laboratories. Recall # D-1349-2022.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.